Perspectives of worldwide translational biomarker research in neurodegenerative diseases

Progress in Neurobiology

Volumn 95, Issue 4, 2011, Pages 496-497

  Nicotera, Pierluigi ^a   Hampel, Harald ^b  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Diagnosis; Etiology; Neurodegeneration; Pathophysiology; Prevention; Prognosis; Risk factors; Systems biology; Translational

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID LEVEL; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DISEASE COURSE; EPIGENETICS; HUMAN; MICROGLIA; NERVE CELL PLASTICITY; NOTE; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; INTERNATIONAL COOPERATION; NEURODEGENERATIVE DISEASES; TRANSLATIONAL MEDICAL RESEARCH;

EID: 82755182821     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2011.07.008     Document Type: Note

References (12)

1. Bano D., Agostini M., Melino G., Nicotera P. Ageing, neuronal connectivity and brain disorders: an unsolved ripple effect. Mol. Neurobiol. 2011, 43:124-130.
2. Bessis A., Béchade C., Bernard D., Roumier A. Microglial control of neuronal death and synaptic properties. Glia 2007, 55:233-238.
3. Blennow K., Hampel H., Weiner M., Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer's disease. Nat. Rev. Neurol. 2010, 6(3):131-144. [Epub 2010 February 16].
4. Braak H., Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol. Scand. Suppl. 1996, 165:3-12.
5. Buschert M., Bokde A., Hampel H. Cognitive intervention in Alzheimer's disease. Nat. Rev. Neurol. 2010, 6(9):508-517. Epub 2010 August 17.
6. Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H. Neuroimaging biomarkers of cognitive decline in preclinical and prodromal Alzheimer's disease. Trends Neurosci., in press.
7. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M., Alzheimer's Disease International Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
8. Hampel H., Wilcock G., Andrieu S., Aisen P., Blennow K., Broich K., Carrillo M., Fox N.C., Frisoni G.B., Isaac M., Lovestone S., Nordberg A., Prvulovic D., Sampaio C., Scheltens P., Weiner M., Winblad B., Coley N., Vellas B., for the Oxford Task Force Group Biomarkers for Alzheimer's disease therapeutic trials. Prog. Neurobiol. 2010, December 2 [Epub ahead of print].
9. Hampel H., Frank R., Broich K., Teipel S.J., Bokde A.L.W., Herholz K., Hardy J., Hoessler Y., Jessen F., Katz R.G., Woodcock J., Zetterberg H., Blennow K. Biomarkers for diagnosis and as endpoints for clinical trials in Alzheimer's disease. Nat. Rev. Drug Discov. 2010, 9(July (7)):560-574.
10. Noorbaksh F., Overall C.M., Power C. Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci. 2009, 32(2):88-100.
11. Palop J.J., Chin J., Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature 2006, 443:768-773.
12. Shen L., Kim S., Risacher S.L., Nho K., Swaminathan S., West J.D., Foroud T., Pankratz N., Moore J.H., Sloan C.D., Huentelman M.J., Craig D.W., Dechairo B.M., Potkin S.G., Jack C.R., Weiner M.W., Saykin A.J., Alzheimer's Disease Neuroimaging Initiative Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: a study of the ADNI cohort. Neuroimage 2010, 53:1051-1063.